Atlas Trials

Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema

Clinical trial NCT01343823 · TERMINATED

Trial details

NCT number
NCT01343823
Sponsor
Shire
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
ACE Inhibitor Induced Angioedema
Start date
2011-06-01
Primary completion
2012-06-01
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.